| Enrolling By Invitation | Post-Operative Antibiotic Efficacy in Clean Contaminated Head and Neck Surgery: A Randomized Controlled Trial NCT06672471 | Shaukat Khanum Memorial Cancer Hospital & Research Centre | N/A |
| Completed | Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma NCT05678348 | Washington University School of Medicine | EARLY_Phase 1 |
| Completed | Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer NCT04865731 | The University of Texas Health Science Center at San Antonio | Phase 2 |
| Completed | Mindfulness-based Stress Reduction Effects on Depression, Anxiety and Internalized Stigma Compared With Treatm NCT06991309 | Universiti Sains Malaysia | N/A |
| Unknown | The Effectiveness of a Thyme and Honey Spray for Oral Toxicities NCT04880148 | Cyprus University of Technology | N/A |
| Recruiting | Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy NCT04470024 | Providence Health & Services | Phase 1 |
| Recruiting | Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal NCT04444869 | University of Missouri-Columbia | Phase 2 |
| Unknown | Effects of Expiratory Muscle Strength Training on Airway Protection and Swallowing in Chronic Dysphagia After NCT03620084 | Singapore General Hospital | N/A |
| Unknown | Head and Neck Cancer in Children: A Retrospective Study NCT02557048 | Assiut University | — |
| Completed | Adjuvant Radiotherapy in Early Stage Oral Cancers NCT03853655 | Tata Memorial Hospital | N/A |
| Terminated | Fluorescence Imaging in Head and Neck Cancer NCT03297957 | Washington University School of Medicine | N/A |
| Completed | Real-time Activity Monitoring to Prevent Admissions During RadioTherapy NCT03102229 | Montefiore Medical Center | N/A |
| Completed | Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcino NCT02573493 | Washington University School of Medicine | Phase 2 |
| Active Not Recruiting | Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carci NCT02270814 | Washington University School of Medicine | Phase 2 |
| Completed | Absorption of Orally Ingested Phosphate in Refeeding Syndrome NCT02880072 | Jens Rikardt Andersen | Phase 4 |
| Completed | A Web-Based Multimedia Intervention for Head and Neck Cancer Patients NCT02442336 | Fox Chase Cancer Center | N/A |
| Completed | PET With [18F]HX4 in Head and Neck Cancer NCT01347281 | Maastricht Radiation Oncology | N/A |
| Completed | Incidence and Risk Factors of Refeeding Syndrome NCT02073032 | University of Copenhagen | — |
| Completed | A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer NCT01283334 | Emory University | Phase 1 / Phase 2 |
| Completed | Evaluation of the Role of Prostaglandins in Radiation-induced Mucositis NCT01252498 | University of Vermont | — |
| Terminated | Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer NCT01370876 | Nang Kuang Pharmaceutical Co., Ltd. | Phase 2 |
| Completed | DAHANCA 24: Prognostic Value of 18F-FAZA in Head and Neck Squamous Cell Carcinoma (HNSCC) NCT01017224 | University of Aarhus | — |
| Completed | Radiotherapy With Humidification in Head And Neck Cancer NCT01917942 | Trans Tasman Radiation Oncology Group | Phase 3 |
| Completed | DAHANCA 19: The Importance of the EGFr-inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for H NCT00496652 | Danish Head and Neck Cancer Group | Phase 3 |
| Completed | Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer NCT00798655 | Robert Ferris | Phase 2 |
| Completed | Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of NCT00474825 | National Baromedical Services | Phase 1 |
| Terminated | Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer NCT00256295 | Sai-Hong Ignatius Ou | Phase 2 |
| Completed | Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation NCT00716157 | Thomas Jefferson University | — |
| Unknown | Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck NCT00180921 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 2 |
| Completed | Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVEN NCT00147472 | Ontario Clinical Oncology Group (OCOG) | Phase 3 |
| Approved For Marketing | An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head a NCT00684385 | AstraZeneca | — |